Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685893 · ClinicalTrials.gov registry record · Phase 3
Integrating Palliative and Critical Care (IPACC) Study
A Phase 3 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,498
- Enrollment target
NCT00685893: Completed Phase 3 study, sponsored by University of Washington.
NCT00685893 is a Phase 3 study that has completed, run by University of Washington. The registered enrollment target is 3,498 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (353% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685893, a Phase 3 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,498 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate an intervention to improve the care given to patients who are dying in the intensive care unit (ICU) and their families. This study is a multi-center randomized trial of a multi-faceted quality improvement intervention designed to improve the quality of palliative and end-of-life care in the ICU setting. The intervention targets the hospital and the outcome evaluation occurs at the level of the individual patient and family with surveys completed by family members and nurses as well as standardized medical record review.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Academic Detailing
- BEHAVIORAL Local Champions
- BEHAVIORAL Institution Feedback
- BEHAVIORAL Institutional Forms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,498 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-10 |
| Phase | Phase 3 |
What the finished NCT00685893 record still lists
NCT00685893 is an interventional study that assigns participants to a tested intervention. Its 3,498 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (353% higher).
The record links to 0 conditions, and to 5 interventions - of which Education is the first listed.
NCT00685893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00685893 about?
NCT00685893 is a clinical study titled "Integrating Palliative and Critical Care (IPACC) Study". The purpose of this research study is to evaluate an intervention to improve the care given to patients who are dying in the intensive care unit (ICU) and their families. This study is a multi-center randomized trial of a multi-faceted quality improvement intervention designed to improve the quality...
What is the current status of trial NCT00685893?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,498 participants. The study started on 2003-06. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00685893?
The interventions under investigation include: Education (BEHAVIORAL), Academic Detailing (BEHAVIORAL), Local Champions (BEHAVIORAL), Institution Feedback (BEHAVIORAL), Institutional Forms (BEHAVIORAL).
Who is sponsoring clinical trial NCT00685893?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00685893's enrollment target sits among peer trials
3,498 70th of 2000 higher than 1,931 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia